In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict clinical response to HER2 targeted therapies Meeting Abstract


Authors: Offin, M.; Olah, Z. T.; Sabari, J. K.; Tandon, N.; Feldman, D.; Abou-Alfa, G. K.; Lok, B. H.; Burck, N.; Tarcic, G.; Miron, B.; Arcila, M. E.; Kris, M. G.; Rudin, C. M.; Li, B. T.
Abstract Title: In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict clinical response to HER2 targeted therapies
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Language: English
ACCESSION: WOS:000411932208142
DOI: 10.1200/JCO.2017.35.15_suppl.e23150
PROVIDER: wos
Notes: Meeting Abstract: e23150 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa
  2. Maria Eugenia Arcila
    657 Arcila
  3. Mark Kris
    869 Kris
  4. Benjamin H Lok
    63 Lok
  5. Benjamin Miron
    5 Miron
  6. Charles Rudin
    488 Rudin
  7. Bob Tingkan Li
    278 Li
  8. Nidhi   Tandon
    9 Tandon
  9. Joshua K Sabari
    36 Sabari
  10. Michael David Offin
    170 Offin
  11. Zachary T Olah
    7 Olah